MedTrace Logo

Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in Korea

NCT05022563 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55759

Last updated 2023-08-03

Study results available
· View outcomes & findings →

Summary

This study is a retrospective, observational, nationwide population-based cohort study utilizing the South Korea's Health Insurance and Review Assessment Service (HIRA) database. The aims of this study are to describe the sociodemographic and clinical characteristics of patients with venous thromboembolism according to their anticoagulant treatment (parenteral anticoagulants, warfarin, or non-vitamin K antagonist oral anticoagulants), to describe the treatment patterns related to anticoagulants, and to examine the risk of major bleeding according to the specific type of oral anticoagulants. The study will be conducted in two phases: Phase I for descriptive study and Phase II for comparative study.

Conditions

  • Venous Thromboembolism

Interventions

DRUG

Parenteral anticoagulant

Parenteral anticoagulant only

DRUG

Warfarin

Warfarin-based

DRUG

Apixaban

Apixaban

DRUG

Rivaroxaban

Rivaroxaban

DRUG

Dabigatran

Dabigatran

DRUG

Edoxaban

Edoxaban

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-31
Primary Completion
2021-09-30
Completion
2021-09-30
FDA Drug
Yes

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05022563 on ClinicalTrials.gov